ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hepatocellular carcinoma"

  • 2019 American Transplant Congress

    Predicting HCC Recurrence Following Liver Transplant – A Machine Learning Approach

    L. F. Lau1, W. Nelson2, A. Gorgen1, L. Erdman2, P. Abreu1, A. Goldenberg2, G. Sapisochin1

    1Department of Surgery, University of Toronto, Toronto, ON, Canada, 2The Center for Computational Medicine, The Hospital for Sick Children, Toronto, ON, Canada

    *Purpose: The liver transplant listing criteria for hepatocellular carcinoma (HCC) is controversial. Policies aim to prevent tumor recurrence but it has been difficult to encompass…
  • 2019 American Transplant Congress

    Hepatocellular Carcinoma in Fontan Liver Disease

    V. Lamm1, J. Wedd2, C. Haydek2, C. Obineme2, A. Noll2, H. Veeramachaneni2, M. Muftah2, R. Ford2

    1Internal Medicine, Emory, Atlanta, GA, 2Emory, Atlanta, GA

    *Purpose: To add to the clinical characteristics and outcomes of hepatocellular carcinoma (HCC) in post Fontan operation patients and present, to the best of our…
  • 2019 American Transplant Congress

    Decreased Cancer Susceptibility in Tolerant Liver Transplant Recipients: Another Benefit of Tolerance?

    M. P. Bhat1, E. Pasini1, C. Baciu1, S. M. Kurian2, J. Levitsky3

    1Multi-Organ Transplant, UHN, Toronto, ON, Canada, 2Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, 3Division of Gastroenterology & Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

    *Purpose: Long-term survival of transplant recipients is significantly impacted by malignancy. Induction of tolerance is feasible in a subset of liver transplant (LT) recipients. The…
  • 2019 American Transplant Congress

    Clinical Presentation After Hepatitis B Recurrence In Liver Transplant Patients

    W. Lee, C. Cheng, T. Wu, Y. Wang, C. Lee, T. Wu, H. Chou, K. Chan

    Chang-Gung Hospital, Taoyuan, Taiwan

    *Purpose: Combination of anti-hepatitis B immunoglobulin and antiviral agents is the standard care for prophylaxis of hepatitis B virus (HBV) recurrence after liver transplantation. However,…
  • 2019 American Transplant Congress

    Spindle and Kinetochore Associated Complex Subunit 3 Promotes Tumor Growth by Regulating CDK2/p53 Phosphorylation in Hepatocellular Carcinoma

    Y. Hou1, Z. Wang2, L. Wu3

    1Organ Transplant Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, 2The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, 3Organ transplant center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

    *Purpose: Spindle and kinetochore-related complex subunit 3 (SKA3) is a part of the spindle and kinetochore-related complexes, which are crucial for the proper timing of…
  • 2019 American Transplant Congress

    The Rapidly Aging Population of Liver Transplant Patients with Hepatocellular Carcinoma

    J. B. Rubin, G. Cullaro, N. Mehta, J. C. Lai

    Division of Gastroenterology & Hepatology, UCSF, San Francisco, CA

    *Purpose: Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer-related mortality in the US and a leading indication for liver transplant (LT). Direct acting…
  • 2019 American Transplant Congress

    Halt-hcc At The Time Of Listing Is Superior To Other Allocation Metrics At Predicting Waitlist Dropout; An Srtr Analysis

    J. C. McVey1, K. Sasaki1, D. J. Firl2, C. M. Miller1, K. Hashimoto1, C. Quintini1, F. N. Aucejo1

    1Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, 2Department of General Surgery, Duke University, Durham, NC

    *Purpose: A recently developed liver allocation metric, Hazard Associated with Liver Transplant for Hepatocellular Carcinoma (HALT-HCC), has been shown to predict post-transplantation survival and recurrence.…
  • 2019 American Transplant Congress

    Impact of Previous Hepatic Resection on the Outcome of Liver Transplantation: A Case-Control Analysis

    M. Serenari, M. Paterno, A. D. Pinna, M. Ravaioli, E. Prosperi, M. Del Gaudio, C. Zanfi, V. Bertuzzo, G. Frascaroli, M. Cescon

    University of Bologna, Bologna, Italy

    *Purpose: The aim of this study was to investigate the impact of HR on the outcome of LT.*Methods: Data of patients treated by LT between…
  • 2019 American Transplant Congress

    Treatment Modality Affects Outcomes of Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A US Multicenter Analysis of 2786 Patients

    P. Tabrizian1, K. J. Halazun2, M. L. Holzner1, N. Mehta3, F. Y. Yao3, J. Roberts3, J. C. Emond4, B. Samstein2, R. S. Brown4, S. Florman1, M. E. Schwartz1, M. M. Doyle5, W. C. Chapman5, M. Najjar4, R. W. Busuttil6, V. G. Agopian6

    1Transplant, Mount Sinai Medical Center, New York, NY, 2Transplant, Weill Cornell Medicine, New York, NY, 3Transplant, University of California San Francisco, San Francisco, CA, 4Transplant, Columbia University Medical Center, New York, NY, 5Transplant, Washington University School of Medicine, St Louis, MO, 6Transplant, David Geffen School of Medicine at UCLA, Los Angeles, CA

    *Purpose: Recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) has a poor prognosis. We evaluated the impact of treatment modalities on post-recurrence survival.*Methods: Adult patients…
  • 2019 American Transplant Congress

    Whole-Exome Sequencing Identifies PMS1 and DYRK1A Genes Contributing to Occurrence of Liver Cancer

    Y. Zhao, B. Yang, D. Chen, L. Wei, Z. Chen

    Tongji hospital, Huazhong university, Organ Transplantation, Wuhan, China

    *Purpose: Liver cancer is one of the most frequent cancers in China and the accurate landscape of liver cancer, especially of HBV-infected liver cancer in…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 23
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences